Trends in Quality of Care for Patients with CKD in the United States
- 11 July 2019
- journal article
- research article
- Published by Wolters Kluwer Health in Clinical Journal of the American Society of Nephrology
- Vol. 14 (8) , 1142-1150
Abstract
Background and objectives: Improving the quality of CKD care has important public health implications to delay disease progression and prevent ESKD. National trends of the quality of CKD care are not well established. Furthermore, it is unknown whether gaps in quality of care are due to lack of physician awareness of CKD status of patients or other factors. Design, setting, participants, & measurements: We performed a national, serial, cross-sectional study of visits to office-based ambulatory care practices for adults with diagnosed CKD from the years 2006 to 2014. We assessed the following quality indicators: (1) BP measurement, (2) uncontrolled hypertension, (3) uncontrolled diabetes, (4) angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use among patients with hypertension, (5) statin use if age ≥50 years old, and (6) nonsteroidal anti-inflammatory drug use. Using multivariable linear regression and chi-squared analysis, we examined the change in quality performance over time. Results: Between 2006 and 2014, there were 7099 unweighted visits for patients with CKD representing 186,961,565 weighted visits. There was no difference in the prevalence of uncontrolled hypertension (>130/80 mm Hg) over time (46% in 2006–2008 versus 48% in 2012–2014; P=0.50). There was a high prevalence of uncontrolled diabetes in 2012–2014 (40% for hemoglobin A1c >7%). The prevalence of ACEi/ARB use decreased from 45% in 2006–2008 to 36% in 2012–2014, which did not reach statistical significance (P=0.07). Statin use in patients with CKD who were 50 years or older was low and remained unchanged from 29% in 2006–2008 to 31% in 2012–2014 (P=0.92). Conclusions: In a nationally representative dataset, we found that patients with CKD had a high prevalence of uncontrolled hypertension and diabetes and a low use of statins that did not improve over time and was not concordant with guidelines.Keywords
Funding Information
- National Institute of Diabetes and Digestive and Kidney Diseases (2T32DK007219-41)
This publication has 50 references indexed in Scilit:
- Evaluation of cardiovascular disease burden and therapeutic goal attainment in US adults with chronic kidney disease: an analysis of national health and nutritional examination survey data, 2001–2010BMC Nephrology, 2013
- Detecting chronic kidney disease in population-based administrative databases using an algorithm of hospital encounter and physician claim codesBMC Nephrology, 2013
- Blood Pressure Components and End-stage Renal Disease in Persons With Chronic Kidney DiseaseArchives of internal medicine (1960), 2012
- Nonsteroidal Anti-Inflammatory Drug Use Among Persons With Chronic Kidney Disease in the United StatesThe Annals of Family Medicine, 2011
- Validation of CKD and Related Conditions in Existing Data Sets: A Systematic ReviewAmerican Journal of Kidney Diseases, 2011
- Primary Care Management of Chronic Kidney DiseaseJournal of General Internal Medicine, 2010
- Hypertension Awareness, Treatment, and Control in Adults With CKD: Results From the Chronic Renal Insufficiency Cohort (CRIC) StudyAmerican Journal of Kidney Diseases, 2010
- Blood Pressure Control Among Persons Without and With Chronic Kidney DiseaseHypertension, 2009
- Standards of Medical Care in Diabetes—2009Diabetes Care, 2009
- Failure of ICD‐9‐CM Codes to Identify Patients with Comorbid Chronic Kidney Disease in DiabetesHealth Services Research, 2005